Avneet Singh (2)
I love traveling and exploring new places. As an SEO Executive at Brevistay, I am working to improve the online presence and website ranking of Brevistay.
Â
Amongst the total players offering bioassay
services for cell and gene therapies, most of
the players engaged in this domain were established before 1995In addition to
this, all of the bioassay service providers (100%) are offering pre-developed
assay. This is followed by 89% players that offer customized cell
therapy assay and gene
therapy assay. Primarily driven by the need for
technical and operational expertise, which are available with contract service
providers, the cell
and gene therapy bioassay services market is poised to
witness substantial growth in the coming years.
Â
To request sample report please visit
https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/request-sample.html
Â
Further, as can be observed from the
figure, 75% service providers claim to have the required capabilities to offer
services related to immunoassay. Besides this, we came across two companies
which offer all the aforementioned bioanalytical services. Examples of such
players include (in alphabetical order), BioAgilytix and PPD Laboratories. It is worth highlighting that, of
the total companies offering bioassay services, close to 60% offer services both
in vitro as well as in vivo type of bioassay for cell and gene therapies.
Â
Â
As the figure represents, majority are
mid-sized players (48%). Of these, most (25%) of companies have been
established between 2000 to 2010. This is followed by the large firms (36%), of
which companies established before 1945 are (in reverse chronological order of year of
establishment) BD Biosciences (1897), Lonza (1897),
SGS (1878), Siemens Healthineers (1847) and Merck KGaA (1668).
Â
Majority of the companies (89%) offer bioassay
services for cell therapies, followed by 86% companies offering bioassay
services for gene therapies. Further, immunoassay was found to be the most
common bioanalytical service, provided by 75% companies. This is followed by potency
assay and ELISA offered by 66% bioassay service providers.
Â
For additional
details, please visitÂ
https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market.html
Â
You may also be
interested in the following titles:
1.    Patient Recruitment and Retention
Services Market (2nd Edition): Industry Trends and
Global Forecasts, 2021-2030
2.    Pharmaceutical
Contract Research Services Market: Industry
Trends and Global Forecasts, 2021-2030
3.    Clinical
Trial Planning and Design Services Market: Industry
Trends and Global Forecasts, 2021-2030
4.    Biospecimen
Contract Research Services Market: Industry
Trends and Global Forecast, 2021-2030
5.    Biologics
Fill / Finish Services Market (2nd Edition): Industry
Trends and Global Forecasts, 2021-2030
Â
About Roots Analysis
Roots Analysis is one of the fastest growing market research
companies, sharing fresh and independent perspectives in the bio-pharmaceutical
industry. The in-depth research, analysis and insights are driven by an
experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at [email protected]
Â
Contact Information
Roots
Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
Article comments